NEW YORK and SAN FRANCISCO, May 11 /PRNewswire/ -- Behrman Capital, a
private investment firm focusing on emerging growth companies, today announced
that Robert F. Byrnes has joined the firm as an operating partner.
Mr. Byrnes, 53, has had a distinguished career as a health care executive
in start-up, mid-size, and Fortune 100 companies covering a wide spectrum of
the health care industry. As an operating partner at Behrman Capital, Mr.
Byrnes will be involved in finding and evaluating potential acquisition
candidates and developing new platforms in the health care services sector for
the firm's continued expansion. He will also work with existing portfolio
companies to add value and will act as a non-executive chairman or board
member for new portfolio companies.
"We are very pleased that someone of Bob Byrnes' outstanding experience
and proven ability is joining our team," said Darryl G. Behrman, a Managing
Partner of Behrman Capital. "Bob has had an extremely successful and diverse
career, serving as business executive, consultant, entrepreneur, turnaround,
and merger expert for both private and public companies. In particular, his
experience ranges from successfully managing specialty drug, device, and
health care service operations, to raising private funding for four start-up
companies, three of which went public. Bob's varied skills, as well as his
broad and deep knowledge of the health care industry and significant
managerial experience, will be invaluable to us and our portfolio companies as
we continue to grow our firm."
In addition to his responsibilities at Behrman Capital, Mr. Byrnes will
continue to serve as President and CEO of ROAN Inc., a consulting firm that
provides strategic, operational and financial advisory services to small and
medium size healthcare organizations.
Prior to creating ROAN Inc. in 1997, Mr. Byrnes served as President and
CEO of Matria Healthcare Inc., a specialty obstetrics and gynecological
(OB/GYN) service organization. He successfully oversaw the creation of Matria
-- which was born out of the March, 1996 merger of Healthdyne, Inc and Tokos
Medical Corporation. Before merging Tokos with Healthdyne, Mr. Byrnes was
Chairman and CEO of Tokos, which under his leadership grew from a start-up
specialty OB/GYN device and service organization into the leading national
provider of OB/GYN homecare services for high-risk, complicated pregnancies.
Mr. Byrnes has also held senior management positions at Caremark, Inc., a
start-up homecare company focusing on patients requiring infusion therapies
and nutritional support; Genentech, Inc., a start-up company which was the
first to develop, manufacture, and market biotech pharmaceuticals; and
American Hospital Supply Corporation, a multinational healthcare company. He
also worked for Abbot Laboratories, Eli Lilly and Co., and Osco Drugs during
the early years of his career.
Over the past sixteen years, Mr. Byrnes has had extensive board
experience, serving as a member of fifteen different Boards of Directors for
non-profit, public and private organizations. He has a B.S. in Pharmacy from
Ferris State University in Big Rapids, Michigan, and an M.B.A. from Loyola
University in Chicago.
Behrman Capital invests in management buyouts of growth companies focused
on the health care services, outsourced manufacturing, and information
technology industries, as well as special situations. The firm also provides
expansion capital to emerging growth companies, principally in the high
technology and health care services industries.
Based in New York City and San Francisco, Behrman Capital was founded in
1992 by Darryl G. and Grant G. Behrman. The firm currently has a combined
capital base exceeding $640 million.
SOURCE Behrman Capital